Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: Rates and duration of subsequent treatment

Drug and Alcohol Dependence

Volumn 104, Issue 1-2, 2009, Pages 100-106

  Stein, Bradley D ^a,b   Kogan, Jane N ^a,b   Sorbero, Mark ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b One Chatham Center ^*  (United States)

Author keywords

Detoxification; Follow up care; Medicaid; Residential treatment

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DETOXIFICATION; DISABLED PERSON; FOLLOW UP; HUMAN; MEDICAID; MENTAL DISEASE; PRIORITY JOURNAL; RESIDENTIAL CARE; SUBSTANCE ABUSE; TREATMENT DURATION; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; HUMANS; LENGTH OF STAY; MALE; MEDICAID; MIDDLE AGED; ODDS RATIO; RESIDENTIAL TREATMENT; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 67651111843     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.04.008     Document Type: Article

References (61)

1. Achieving the Promise: Transforming Mental Health Care in America. Publication number SMA-03-3832. Rockville, Md, Department of Health and Human Services, President's New Freedom Commision on Mental Health, 2003.
2. Adelmann P.K. Mental and substance use disorders among Medicaid recipients: prevalence estimates from two national surveys. Adm. Policy Ment. Health 31 (2003) 111-129
3. Alegria M., Canino G., Rios R., Vera M., Calderon J., Rusch D., and Ortega A.N. Mental health care for Latinos: inequalities in use of specialty mental health services among Latinos, African Americans, and non-Latino Whites. Psychiatr. Serv. 53 (2002) 1547-1555
4. Anderson L.M., Scrimshaw S.C., Fullilove M.T., Fielding J.E., and Normand J. Culturally competent healthcare systems. A systematic review. Am. J. Prev. Med. 24 (2003) 68-79
5. Booth B.M., Cook C.L., Blow F.C., and Bunn J.Y. Utilization of outpatient mental health services after inpatient alcoholism treatment. J. Ment. Health Admin. 19 (1992) 21-30
6. Borders T.F., and Booth B.M. Research on rural residence and access to drug abuse services: where are we and where do we go?. J. Rural Health 23 Suppl. (2007) 79-83
7. Botticelli M. Massachusetts performance management initiative; ATS pay-for-performance project. State System's Development Program Conference: Partnering to Support Recovery-oriented Systems of Care. Washington, DC (2008)
8. Boyer C.A., McAlpine D.D., Pottick K.J., and Olfson M. Identifying risk factors and key strategies in linkage to outpatient psychiatric care. Am. J. Psychiatry 157 (2000) 1592-1598
9. Capoccia V.A., Cotter F., Gustafson D.H., Cassidy E.F., Ford II J.H., Madden L., Owens B.H., Farnum S.O., McCarty D., and Molfenter T. Making "stone soup": improvements in clinic access and retention in addiction treatment. Jt. Comm. J. Qual. Patient Saf. 33 (2007) 95-103
10. Chutuape M.A., Katz E.C., and Stitzer M.L. Methods for enhancing transition of substance dependent patients from inpatient to outpatient treatment. Drug Alcohol Depend. 61 (2001) 137-143
11. Daley M.C. Race, managed care, and the quality of substance abuse treatment. Adm. Policy Ment. Health 32 (2005) 457-476
12. Ford II J.H., Green C.A., Hoffman K.A., Wisdom J.P., Riley K.J., Bergmann L., and Molfenter T. Process improvement needs in substance abuse treatment: admissions walk-through results. J. Subst. Abuse Treat. 33 (2007) 379-389
13. Fulco C.E., Liverman C.T., and Earley L.E. Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector (1995), National Academy Press, Washington, DC
14. Garnick D.W., Lee M.T., Horgan C.M., and Acevedo A. Adapting Washington Circle performance measures for public sector substance abuse treatment systems. J. Subst. Abuse Treat. (2008)
15. Gawande A. The Bell Curve (2004), The New Yorker, New York
16. Gerstein D.R., and Harwood H.J. Treating Drug Problems: A Study of the Evolution, Effectiveness, and Financing of Public and Private Drug Treatment Systems (1990), National Academy Press, Washington, DC
17. Gillispie R., Williams E., and Gillispie C. Hospitalized African American mental health consumers: some antecedents to service satisfaction and intent to comply with aftercare. Am. J. Orthopsychiatry 75 (2005) 254-261
18. Harwood H. Updating Estimates of the Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods, and Data (2000), National Institute on Drug Abuse, National Institute on Alcohol and Alcoholism, National Institutes of Health, Department of Health and Human Services, Rockville, MD
19. Hauenstein E.J., Petterson S., Merwin E., Rovnyak V., Heise B., and Wagner D. Rurality, gender, and mental health treatment. Fam. Community Health 29 (2006) 169-185
20. Hermann R.C., and Palmer R.H. Common ground: a framework for selecting core quality measures for mental health and substance abuse care. Psychiatr. Serv. 53 (2002) 281-287
21. Hermann R.C., and Provost S. Best practices: interpreting measurement data for quality improvement: standards, means, norms, and benchmarks. Psychiatr. Serv. 54 (2003) 655-657
22. Hoffman K.A., Ford II J.H., Choi D., Gustafson D.H., and McCarty D. Replication and sustainability of improved access and retention within the network for the improvement of addiction treatment. Drug Alcohol Depend. 98 (2008) 63-69
23. Institute of Medicine Committee on Crossing the Quality Chasm. Coordinating care for better mental, substance-use, and general health. Improving the Quality of Health Care for Mental and Substance-use Conditions (2006), National Academies Press, Washington, DC p. 504 (Chapter 5)
24. Johnson M.E., Brems C., Warner T.D., and Roberts L.W. Rural-urban health care provider disparities in Alaska and New Mexico. Adm. Policy Ment. Health 33 (2006) 504-507
25. Kiefe C.I., Allison J.J., Williams O.D., Person S.D., Weaver M.T., and Weissman N.W. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA 285 (2001) 2871-2879
26. Lash S.J. Increasing participation in substance abuse aftercare treatment. Am. J. Drug Alcohol Abuse 24 (1998) 31-36
27. Mark T.L., Dilonardo J.D., Chalk M., and Coffey R. Factors associated with the receipt of treatment following detoxification. J. Subst. Abuse Treat. 24 (2003) 299-304
28. Mark T.L., Vandivort-Warren R., and Montejano L.B. Factors affecting detoxification readmission: analysis of public sector data from three states. J. Subst. Abuse Treat. 31 (2006) 439-445
29. Marshall M.N., Shekelle P.G., Leatherman S., and Brook R.H. The public release of performance data: what do we expect to gain? A review of the evidence. JAMA 283 (2000) 1866-1874
30. McCarty D., Gustafson D.H., Wisdom J.P., Ford J., Choi D., Molfenter T., Capoccia V., and Cotter F. The Network for the Improvement of Addiction Treatment (NIATx): enhancing access and retention. Drug Alcohol Depend. 88 (2007) 138-145
31. McCorry F., Garnick D.W., Bartlett J., Cotter F., and Chalk M. Developing performance measures for alcohol and other drug services in managed care plans. Jt. Comm. J. Qual. Improv. 26 (2000) 633-643
32. McLellan A.T., Carise D., and Kleber H.D. Can the national addiction treatment infrastructure support the public's demand for quality care?. J. Subst. Abuse Treat. 25 (2003) 117-121
33. McLellan A.T., Lewis D.C., O'Brien C.P., and Kleber H.D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284 (2000) 1689-1695
34. Moos R.H., Brennan P.L., and Mertens J.R. Diagnostic subgroups and predictors of one-year re-admission among late-middle-aged and older substance abuse patients. J. Stud. Alcohol 55 (1994) 173-183
35. Moos R.H., Finney J.W., and Cronkite R.C. Alcoholism Treatment: Context, Process, and Outcome (1990), Oxford University Press, New York, NY
36. Moos R.H., and Moos B.S. Long-term influence of duration and intensity of treatment on previously untreated individuals with alcohol use disorders. Addiction 98 (2003) 325-337
37. Moos R.H., Moos B.S., and Finney J.W. Predictors of deterioration among patients with substance-use disorders. J. Clin. Psychol. 57 (2001) 1403-1419
38. NIATx. Approaches and Strategies for Improving Continuation and No-Shows in Early Treatment. (Accessed 21.01.09) (2009). http://www.niatx.net/Content/ContentPage.aspx?NID=102
39. O'Connor G.T., Quinton H.B., Traven N.D., Ramunno L.D., Dodds T.A., Marciniak T.A., and Wennberg J.E. Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA 281 (1999) 627-633
40. Office of National Drug Control Policy. The Economic Costs of Drug Abuse in the United States 1992-2002 (2004), Office of National Drug Control Policy, Washington, DC
41. Raggio S., Jackson S., and Sullivan M. Improving services by holding hands, not pointing fingers. Behav. Healthc. 26 (2006) 36-39
42. Rost K., Fortney J., Fischer E., and Smith J. Use, quality, and outcomes of care for mental health: the rural perspective. Med. Care Res. Rev. 59 (2002) 231-265
43. Simpson D.D. The relation of time spent in drug abuse treatment to posttreatment outcome. Am. J. Psychiatry 136 (1979) 1449-1453
44. Simpson D.D., Joe G.W., and Broome K.M. A national 5-year follow-up of treatment outcomes for cocaine dependence. Arch. Gen. Psychiatry 59 (2002) 538-544
45. Stein B., Orlando M., and Sturm R. The effect of copayments on drug and alcohol treatment following inpatient detoxification under managed care. Psychiatr. Serv. 51 (2000) 195-198
46. Stein B.D., Kogan J.N., Sorbero M.J., Thompson W., and Hutchinson S.L. Predictors of timely follow-up care among medicaid-enrolled adults after psychiatric hospitalization. Psychiatr. Serv. 58 (2007) 1563-1569
47. Stein B.D., and Zhang W. Drug and alcohol treatment among privately insured patients: rate of speciality substance abuse treatment and association with cost-sharing. Drug Alcohol Depend. 71 (2003) 153-159
48. Substance Abuse Mental Health Services Administration Office of Applied Studies. Results from the 2006 National Survey on Drug Use and Health: National Findings. (Accessed 05.06.2008) (2006). http://www.oas.samhsa.gov/NSDUH/2k6nsduh/2k6results.cfm#7.2
49. SAS Software, Version 9.1 of the SAS System for Windows. Cary, NC, SAS, 2004.
50. Swanson A.J., Pantalon M.V., and Cohen K.R. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. J. Nerv. Ment. Dis. 187 (1999) 630-635
51. Taylor S.L., and Lurie N. The role of culturally competent communication in reducing ethnic and racial healthcare disparities. Am. J. Manage. Care 10 (2004) 1-4
52. US Public Health Service, Office of the Surgeon General, Center for Mental Health Services (U.S.), National Institute of Mental Health (U.S.), United States, and Substance Abuse Mental Health Services Administration. Mental health: culture, race, and ethnicity. A Supplement to Mental Health: A Report of the Surgeon General (2001), Dept. of Health and Human Services, Rockville, MD
53. Walker R.D., Donovan D.M., Kivlahan D.R., and O'Leary M.R. Length of stay, neuropsychological performance, and aftercare: influences on alcohol treatment outcome. J. Consult. Clin. Psychol. 51 (1983) 900-911
54. Wang P.S., Demler O., and Kessler R.C. Adequacy of treatment for serious mental illness in the United States. Am. J. Public Health 92 (2002) 92-98
55. Watkins K.E., Burnam A., Kung F.Y., and Paddock S. A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatr. Serv. 52 (2001) 1062-1068
56. Watkins K.E., Hunter S.B., Burnam M.A., Pincus H.A., and Nicholson G. Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder. Psychiatr. Serv. 56 (2005) 913-926
57. Weisner C., and Schmidt L. Alcohol and drug problems among diverse health and social service populations. Am. J. Public Health 83 (1993) 824-829
58. Wells K., Klap R., Koike A., and Sherbourne C. Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care. Am. J. Psychiatry 158 (2001) 2027-2032
59. Wennberg, J. E., Fisher, E. S., Stukel, T. A., Sharp, S. M., 2004. Use of Medicare Claims Data To Monitor Provider-Specific Performance Among Patients With Severe Chronic Illness. Health Affairs Web Exclusive, October 7.
60. Young A.S., Klap R., Sherbourne C.D., and Wells K.B. The quality of care for depressive and anxiety disorders in the United States. Arch. Gen. Psychiatry 58 (2001) 55-61
61. Zito J.M., Safer D.J., Zuckerman I.H., Gardner J.F., and Soeken K. Effect of medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatr. Serv. 56 (2005) 157-163